The Amend system delivers a closed, D-shaped, semi-rigid annuloplasty ring through a catheter in a transseptal approach.

WILMINGTON, Del., Feb. 11, 2026 /PRNewswire/ -- Valcare Medical, Inc., a pioneer developer in transcatheter mitral valve repair solutions, today announced the successful first U.S. transseptal ...

We conducted a randomized, controlled trial involving patients with heart failure and moderate to severe functional mitral regurgitation from 30 sites in nine countries. The patients were assigned in ...

Please provide your email address to receive an email when new articles are posted on . Compared with surgical ligation, transcatheter closure of the patent ductus arteriosus in infants and neonates ...

A major highlight of 2025 was the rapid progress in artificial intelligence (AI) for the detection and assessment of VHD.

The FDA approved the Evoque tricuspid valve replacement system as the first transcatheter treatment for tricuspid regurgitation (TR), Edwards Lifesciences announced. Evoque gained an indication for ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter tricuspid valve replacement plus medical therapy improved outcomes vs. medical therapy alone in ...

The largest study to examine outcomes for patients treated outside a clinical trial setting with a minimally invasive procedure to repair a poorly functioning mitral valve in the heart found that the ...

San Francisco — In the first randomized controlled trial using the TriClip Transcatheter Tricuspid Valve Repair system (Abbott) for transcatheter edge-to-edge repair (TEER) of the tricuspid valve in ...

SAN FRANCISCO, CA—Transcatheter mitral valve-in-valve procedures, especially those done via transseptal access, are associated with low mortality and adverse event rates as well as quality-of-life ...

Transcatheter tricuspid-valve replacement is superior to medical therapy alone for patients with severe tricuspid regurgitation, according to a study published online Oct. 30 in the New England ...